The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA(1c) in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)

OBJECTIVE: To demonstrate that Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support significantly improves HbA(1c) in poorly controlled type 1 diabetic patients. RESEARCH DESIGN AND METHODS: In a six-month open-label parallel-group, multicenter study, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Charpentier, Guillaume, Benhamou, Pierre-Yves, Dardari, Dured, Clergeot, Annie, Franc, Sylvia, Schaepelynck-Belicar, Pauline, Catargi, Bogdan, Melki, Vincent, Chaillous, Lucy, Farret, Anne, Bosson, Jean-Luc, Penfornis, Alfred
Format: Artigo
Language:Inglês
Published: American Diabetes Association 2011
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3041176/
https://ncbi.nlm.nih.gov/pubmed/21266648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-1259
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items